Patents by Inventor Christine Buerki

Christine Buerki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL-AFFINITY PROBES AND SYSTEMS FOR ANALYTE DETECTION
    Publication number: 20240036044
    Abstract: The present document describes a dual-affinity probe comprising an organic or inorganic surface binding peptide and a target-specific capture element, which may bind to various targets, such as pathogens. This document further describes uses of the dual-affinity probe, and kits to determine the presence of and/or quantity of a target in a sample. In particular embodiments, the dual-affinity probe is specific for SARS-CoV-2 (Spike or Nucleocapsid) protein and may be used to determine whether a subject is infected with SARS-CoV-2.
    Type: Application
    Filed: March 9, 2023
    Publication date: February 1, 2024
    Inventors: Robert Crandall Greene, Christine BUERKI
  • DUAL-AFFINITY PROBES FOR ANALYTE DETECTION
    Publication number: 20230341395
    Abstract: The present document describes a dual-affinity probe comprising an inorganic surface binding peptide and a target-specific capture element, which may bind to various targets, such as pathogens. This document further describes uses of the dual-affinity probe, e.g., to determine the presence of and/or quantity of a target in a sample. In particular embodiments, the dual-affinity probe is specific for SARS-CoV-2 (Spike or Nucleocapsid) protein and may be used to determine whether a subject is infected with SARS-CoV-2.
    Type: Application
    Filed: September 10, 2021
    Publication date: October 26, 2023
    Inventors: Robert Crandall GREENE, Christine BUERKI, Oscar URTATIZ
  • CANCER DIAGNOSTICS USING BIOMARKERS
    Publication number: 20220349011
    Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
    Type: Application
    Filed: June 11, 2021
    Publication date: November 3, 2022
    Inventors: Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
  • Cancer diagnostics using biomarkers
    Patent number: 11035005
    Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: June 15, 2021
    Assignees: Decipher Biosciences, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
  • CANCER DIAGNOSTICS USING BIOMARKERS
    Publication number: 20140066323
    Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
    Type: Application
    Filed: August 16, 2013
    Publication date: March 6, 2014
    Applicants: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, GENOMEDX BIOSCIENCES INC.
    Inventors: Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
  • PROGNOSTIC AND PREDICTIVE GENE SIGNATURE FOR NON-SMALL CELL LUNG CANCER AND ADJUVANT CHEMOTHERAPY
    Publication number: 20120077687
    Abstract: The application provides methods of prognosing and classifying lung cancer patients into poor survival groups or good survival groups and for determining the benefit of adjuvant chemotherapy by way of a multigene signature. The application also includes kits and computer products for use in the methods of the application.
    Type: Application
    Filed: June 20, 2011
    Publication date: March 29, 2012
    Inventors: Fadia SAAD, Jonathan C. Schisler, Joel Parker, Christine Buerki